FSD Pharma (TSE:HUGE) has released an update.
FSD Pharma Inc. has triumphed in a legal battle against its former CEO, Dr. Raza Bokhari, with the U.S. District Court for the Eastern District of Pennsylvania confirming a sizable arbitration award of over $3 million plus interest. The decision follows a protracted legal struggle, including an eight-day hearing, after Bokhari contested his termination in 2021. FSD Pharma is now set on collecting the awarded damages from Bokhari, who currently leads Medicus Pharma Ltd.
For further insights into TSE:HUGE stock, check out TipRanks’ Stock Analysis page.
